CHROMOCELL THERAPEUTICS CORPORATION

Otros idiomas Chromocell Therapeutics Corporation

Acciones

CHRO

US1711261057

Mercado cerrado - Nyse Otros sitios de cotización 22:10:00 07/06/2024			Varia. Cinco días.	Varia. 1 de enero.
1,42 ^USD	-4,05 %		+5,97 %	0,00 %

15/05	Chromocell Therapeutics Corporation presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
16/04	Chromocell Therapeutics Corporation informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13/05
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13/05
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Chromocell Issues Letter to Stockholders from Chief Executive Officer	09/04
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler	21/03
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program	21/03
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18/03
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18/03
Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO	18/03
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11/03
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11/03
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions	27/02
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million	21/02
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.	15/02
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/01
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01/09/23
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	30/06/23
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Bolsa de valores
Acciones
Acción CHRO
Noticias Chromocell Therapeutics Corporation
Otros idiomas

Descubra nuestros Contenidos Gratuitos para Ayudarle a Entender Mejor los Mercados bursátiles.

Inscripción 100% Gratuita

fermer